Madrigal Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2011 | — | $14.8M | $30.1M |
| FY2012 | — | $75.1M | $81.5M |
| FY2013 | — | $49.1M | $48.5M |
| FY2014 | — | $-42.1M | $148.1K |
| FY2015 | — | $-48.9M | $306.0K |
| FY2016 | — | $36.4M | $19.1M |
| FY2017 | — | $182.3M | $148.6M |
| FY2018 | — | $477.0M | $57.4M |
| FY2019 | — | $416.6M | $46.7M |
| FY2020 | — | $240.0M | $54.0M |